{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:56:27Z","timestamp":1771548987103,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006694","name":"Associazione Italiana Contro le Leucemie-Linfomi e Mieloma ONLUS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.humpath.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:31:25Z","timestamp":1648038685000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation"],"prefix":"10.1016","volume":"124","author":[{"given":"Simona","family":"Righi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Novero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Godio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Sagramoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Piccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mannu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.03.008_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1179\/1607845415Y.0000000005","article-title":"Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly","volume":"20","author":"Sreedharanunni","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.humpath.2022.03.008_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1309\/MECJ-GLK1-WEBW-UEVE","article-title":"Comparative study of marginal zone Lymphoma involving bone marrow","volume":"117","author":"Kent","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3816\/CLM.2005.n.003","article-title":"Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?","volume":"5","author":"Berger","year":"2005","journal-title":"Clinical Lymphoma"},{"key":"10.1016\/j.humpath.2022.03.008_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jclinpath-2013-201520","article-title":"Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings","volume":"67","author":"Sovani","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1309\/AJCP6ZODWV1CIDME","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature","volume":"143","author":"Bassarova","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib7","series-title":"WHO classification of tumours","first-page":"266","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2022.03.008_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1309\/AJCP10ZCLFZGYZIP","article-title":"MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders","volume":"140","author":"Ondrejka","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.03.008_bib11","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","article-title":"Systematic review of somatic mutations in splenic marginal zone lymphoma","volume":"9","author":"Jaramillo","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2022.03.008_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.03.008_bib13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.008_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2012-12-475111","article-title":"A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstr\u00f6m macroglobulinemia","volume":"122","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.008_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1078155218786037","article-title":"Ibrutinib in the management of Waldenstrom macroglobulinemia","volume":"25","author":"Yosef","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.humpath.2022.03.008_bib17","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2217\/fon-2018-0163","article-title":"Head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenstr\u00f6m macroglobulinemia","volume":"14","author":"Tam","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.humpath.2022.03.008_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdn563","article-title":"Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients","volume":"20","author":"Boveri","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.03.008_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.03.008_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/his.12160","article-title":"Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers","volume":"63","author":"Bob","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.03.008_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2016.09.011","article-title":"Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma","volume":"59","author":"Ikeda","year":"2017","journal-title":"Human Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ajcp\/aqy144","article-title":"IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification","volume":"151","author":"Wang","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.03.008_bib25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.humpath.2014.04.004","article-title":"Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma","volume":"45","author":"Metcalf","year":"2014","journal-title":"Human Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAI.0000000000000738","article-title":"Myeloid cell nuclear differentiation antigen (MNDA) positivity in primary follicles: potential pitfall in the differential diagnosis with marginal zone lymphoma","volume":"28","author":"Manohar","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.03.008_bib27","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissue, lymphoplasmacytic lymphoma","first-page":"194","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2022.03.008_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2016.09.018","article-title":"Reproducibility of SOX11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients","volume":"59","author":"Righi","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3892\/mco.2017.1225","article-title":"p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation","volume":"6","author":"Pich","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.humpath.2022.03.008_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.03.008_bib31","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.008_bib32","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/PAS.0b013e318271243d","article-title":"Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?","volume":"36","author":"Ponzoni","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.008_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","article-title":"Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations","volume":"129","author":"Curiel-Olmo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.008_bib34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/10428194.2016.1196813","article-title":"Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies","volume":"58","author":"Traverse-Glehen","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.03.008_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","article-title":"Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma","volume":"102","author":"Jallades","year":"2017","journal-title":"Haematologica"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:58Z","timestamp":1758645598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":35,"alternative-id":["S0046817722000727"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}